首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Cell Therapy Using Bone Marrow-Derived Stem Cell Overexpressing BMP-7 for Degenerative Discs in a Rat Tail Disc Model
【2h】

Cell Therapy Using Bone Marrow-Derived Stem Cell Overexpressing BMP-7 for Degenerative Discs in a Rat Tail Disc Model

机译:在大鼠尾椎间盘模型中使用骨髓衍生的干细胞过表达BMP-7对变性椎间盘进行细胞治疗。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Degenerative discs can cause low back pain. Cell-based transplantation or growth factors therapy have been suggested as a strategy to stimulate disc regeneration. Bone marrow-derived mesenchymal stem cells (BMDMSC) containing bone morphogenetic protein-7 (BMP-7) gene were constructed. We evaluated the effectiveness of these BMP-7 overexpressing cells on degenerative discs in rat tails. In vitro and in vivo studies were designed. In the first stage, the rats were divided into two group according to discs punctured by different needle gauges (18 gauge and 22 gauge). In the second stage, the ideal size of needle was used to induce rat tail disc degeneration. These animals are divided into three groups according to timing of treatment (zero-week, two-week, four-week). Each group was divided into three treating subgroups: control group, BMDMSC group, and Baculo-BMP-7-BMDMSC group. Each rat undergoes radiography examination every two weeks. After eight weeks, the discs were histologically examined with hematoxylin and eosin stain and Alcian blue stain. The 18-gauge group exhibited significant decrease in disc height index (%) than 22-gauge group at eight weeks at both Co6-7 (58.1% ± 2.8% vs. 63.7% ± 1.0%, p = 0.020) and Co8-9 discs (62.7% ± 2.8% vs. 62.8% ± 1.5%, p = 0.010). Baculo-BMP-7-BMDMSCs group showed significant difference in disc height index compared to the BMDMSCs group at both Co6-7 (93.7% ± 1.5% vs. 84.8% ± 1.0%, p = 0.011) and Co8-9 (86.0% ± 2.1% vs. 81.8% ± 1.7%, p = 0.012). In Baculo-BMP-7-BMDMSCs group, the zero-week treatment subgroup showed significant better in disc height index compared to two-week treatment group (p = 0.044), and four-week treatment group (p = 0.011). The zero-week treatment subgroup in Baculo-BMP-7-BMDMSCs group also had significant lower histology score than two-week treatment (4.3 vs. 5.7, p = 0.045) and four-week treatment (4.3 vs. 6.0, p = 0.031). In conclusion, Baculo-BMP-7-BMDMSC can slow down the progression of disc degeneration, but could not provide evidence of regeneration. Early treatment might obtain more distinct results.
机译:椎间盘退变会引起腰痛。已经提出了基于细胞的移植或生长因子疗法作为刺激椎间盘再生的策略。构建了含有骨形态发生蛋白7(BMP-7)基因的骨髓间充质干细胞(BMDMSC)。我们评估了这些BMP-7过表达细胞在大鼠尾巴的退化性椎间盘上的有效性。设计了体外和体内研究。在第一阶段,根据不同针规(18规和22规)刺穿的椎间盘将大鼠分为两组。在第二阶段,使用理想的针头尺寸诱发大鼠尾椎间盘退变。根据治疗时间将这些动物分为三组(零周,两周,四周)。每组分为三个治疗亚组:对照组,BMDMSC组和Baculo-BMP-7-BMDMSC组。每只大鼠每两周接受一次射线照相检查。八周后,用苏木精和曙红染色以及阿尔辛蓝染色对光盘进行组织学检查。在Co6-7和Co8-9的情况下,第18规格的组在8周时的椎间盘高度指数(%)明显低于22规格的组(58.1%±2.8%vs. 63.7%±1.0%,p = 0.020)。光盘(62.7%±2.8%与62.8%±1.5%,p = 0.010)。 Baculo-BMP-7-BMDMSCs组在Co6-7(93.7%±1.5%vs. 84.8%±1.0%,p = 0.011)和Co8-9(86.0%)方面均显示出与BMDMSCs组相比的椎间盘高度指数差异±2.1%与81.8%±1.7%,p = 0.012)。在Baculo-BMP-7-BMDMSCs组中,零周治疗亚组的椎间盘高度指数显着优于两周治疗组(p = 0.044)和四周治疗组(p = 0.011)。 Baculo-BMP-7-BMDMSCs组的零周治疗亚组的组织学评分也显着低于两周治疗(4.3 vs. 5.7,p = 0.045)和四周治疗(4.3 vs. 6.0,p = 0.031) )。总之,Baculo-BMP-7-BMDMSC可以减慢椎间盘退变的进程,但不能提供再生证据。早期治疗可能会获得更明显的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号